Clinical trial
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
NCT00404625 · University of Siena, Other · Unknown status
Key facts
| NCT number | NCT00404625 |
|---|---|
| Title | Infections Caused by ESbL-Producing Enterobacteriaceae in Italy |
| Official title | Infections Caused by Enterobacteriaceae Producing Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology, Clinical Impact, Treatment Outcome and Risk Factors |
| Lead sponsor | University of Siena, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Enterobacteriaceae Infections, Bacteremia, Pneumonia, Skin Diseases, Urinary Tract Infections |
| Intervention type | Behavioral |
| Interventions | Risk factors for infections due to ESBL+ Enterobacteriaceae, Risk factors for inadequate initial antimicrobial therapy, Overall and 30-day mortality in bad first antibiotic therapy |
| Enrollment | 813 |
| Start date | Oct 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 29, 2006 |
| Last update posted | Nov 29, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: